Literature DB >> 3126255

Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein.

P Bacha1, D P Williams, C Waters, J M Williams, J R Murphy, T B Strom.   

Abstract

The IL-2 toxin-mediated inhibition of protein synthesis in high affinity IL-2-R-positive murine and human T cell lines has been examined. Both excess free IL-2 and mAb to the Tac epitope of the p55 subunit of IL-2-R are shown to block the action of IL-2 toxin; whereas, agents that interact with other receptors or antigens on the T cell surface have no effect. We show that IL-2 toxin, like diphtheria toxin, must pass through an acidic vesicle in order to intoxicate target T cells. Finally, we demonstrate that the IL-2 toxin-mediated inhibition of protein synthesis in both human and murine T cells that bear the high affinity IL-2-R is due to the classic diphtheria toxin fragment A-catalyzed ADP ribosylation of elongation factor 2.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3126255      PMCID: PMC2188856          DOI: 10.1084/jem.167.2.612

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

Review 2.  Diphtheria toxin.

Authors:  A M Pappenheimer
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

3.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; T Akagi; Y Ohtsuki; Y Shiraishi; K Nagata; Y Hinuma
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

4.  Entry of the toxic proteins abrin, modeccin, ricin, and diphtheria toxin into cells. II. Effect of pH, metabolic inhibitors, and ionophores and evidence for toxin penetration from endocytotic vesicles.

Authors:  K Sandvig; S Olsnes
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

5.  Association of diphtheria toxin with Vero cells. Demonstration of a receptor.

Authors:  J L Middlebrook; R B Dorland; S H Leppla
Journal:  J Biol Chem       Date:  1978-10-25       Impact factor: 5.157

6.  Kinetics of adenosinediphosphoribosylation of elongation factor 2 in cells exposed to diphtheria toxin.

Authors:  M R Moynihan; A M Pappenheimer
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

7.  Rapid entry of nicked diphtheria toxin into cells at low pH. Characterization of the entry process and effects of low pH on the toxin molecule.

Authors:  K Sandvig; S Olsnes
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

8.  In vitro inhibition of diphtheria toxin action by ammonium salts and amines.

Authors:  K Kim; N B Groman
Journal:  J Bacteriol       Date:  1965-12       Impact factor: 3.490

9.  Molecular, cellular, and functional properties of bone marrow T lymphocyte progenitor clones.

Authors:  R Palacios; M Kiefer; M Brockhaus; K Karjalainen; Z Dembić; P Kisielow; H von Boehmer
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

10.  T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Authors:  R J Robb; A Munck; K A Smith
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  34 in total

Review 1.  Immunotherapy through the IL-2 receptor.

Authors:  H A Verheul; M Verveld; E S Bos
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 2.  Immunotoxins for targeted cancer therapy.

Authors:  Robert J Kreitman
Journal:  AAPS J       Date:  2006-08-18       Impact factor: 4.009

3.  2006 Homer W. Smith Lecture: taming T cells.

Authors:  Terry B Strom
Journal:  J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 10.121

4.  Pharmacokinetics of the recombinant fusion protein DAB486IL-2 in animal models.

Authors:  P Bacha; S Forte; N Kassam; J Thomas; D Akiyoshi; C Waters; J Nichols; M Rosenblum
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Essential lysine residues within transmembrane helix 1 of diphtheria toxin facilitate COPI binding and catalytic domain entry.

Authors:  Carolina Trujillo; Julian Taylor-Parker; Robert Harrison; John R Murphy
Journal:  Mol Microbiol       Date:  2010-04-14       Impact factor: 3.501

6.  DAB389IL-2 recombinant fusion toxin effect on lymphocyte- and macrophage-producing cytokine subpopulation cells in experimentally induced demyelinating disease in mice.

Authors:  Mahendra K Bhopale; Brendan Hilliard; Cris S Constantinescu; S Michael Phillips; Abdolmohamad Rostami
Journal:  Immunopharmacol Immunotoxicol       Date:  2017-09-20       Impact factor: 2.730

7.  Diphtheria toxin-related cytokine fusion proteins: elongation factor 2 as a target for the treatment of neoplastic disease.

Authors:  J vanderSpek; L Cosenza; T Woodworth; J C Nichols; J R Murphy
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

8.  Interleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivo.

Authors:  V E Kelley; P Bacha; O Pankewycz; J C Nichols; J R Murphy; T B Strom
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

9.  Human fusion proteins between interleukin 2 and IgM heavy chain are cytotoxic for cells expressing the interleukin 2 receptor.

Authors:  H Vié; T Gauthier; R Breathnach; M Bonneville; A Godard; J Dietrich; G Karam; M C Gesnel; M A Peyrat; Y Jacques; J P Soulillou
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

10.  Denileukin diftitox for the treatment of cutaneous T-cell lymphoma.

Authors:  David Kaminetzky; Kenneth B Hymes
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.